Preclinical development of AMG 139, a human antibody specifically targeting IL‐23 von Köck, K, Pan, W J, Gow, J M, Horner, M J, Gibbs, J P, Colbert, A, Goletz, T J, Newhall, K J, Rees, W A, Sun, Y, Zhang, Y, O'Neill, J C, Umble‐Romero, A N, Prokop, S P, Krill, C D, Som, L, Buntich, S A, Trimble, M W, Tsuji, W H, Towne, J E

Volltext

Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys von Ominsky, Michael S, Boyd, Steven K, Varela, Aurore, Jolette, Jacquelin, Felx, Melanie, Doyle, Nancy, Mellal, Nacera, Smith, Susan Y, Locher, Kathrin, Buntich, Sabina, Pyrah, Ian, Boyce, Rogely W

Volltext

Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study von Chouinard, Luc, Felx, Melanie, Mellal, Nacera, Varela, Aurora, Mann, Peter, Jolette, Jacquelin, Samadfam, Rana, Smith, Susan Y., Locher, Kathrin, Buntich, Sabina, Ominsky, Michael S., Pyrah, Ian, Boyce, Rogely Waite

Volltext

Robotic animal-assisted therapy as a complementary therapy in clinical practice: Exploring animal-assisted intervention professional perspectives von Burr, Macy, Buntich, Jordan, Gonzalez, Marissa, Miranda, Stephanie, Vu, Tuyen

Volltext

Modeling the pharmacokinetic‐pharmacodynamic relationship of the monoclonal anti‐macaque‐IL‐15 antibody Hu714MuXHu in cynomolgus monkeys von Pan, Wei. J., Li, Hong, Xiao, Jim J., Horner, Michelle J., Lebrec, Herve N., Butz, Eric A., Kaliyaperumal, Arunan, Cheah, Tsui C., Ortiz, Robert C., Prokop, Samantha P., Buntich, Sabina A., Boren, Babette M., Wolford, Suzanne T., Tsuji, Wayne H., Wienkers, Larry C., Köck, Kathleen

Volltext

Modeling the pharmacokinetic‐pharmacodynamic relationship of the monoclonal anti‐macaque‐ IL ‐15 antibody Hu714Mu XH u in cynomolgus monkeys von Pan, Wei. J., Li, Hong, Xiao, Jim J., Horner, Michelle J., Lebrec, Herve N., Butz, Eric A., Kaliyaperumal, Arunan, Cheah, Tsui C., Ortiz, Robert C., Prokop, Samantha P., Buntich, Sabina A., Boren, Babette M., Wolford, Suzanne T., Tsuji, Wayne H., Wienkers, Larry C., Köck, Kathleen

Volltext

Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats von Taylor, Scott, Ominsky, Michael S, Hu, Rong, Pacheco, Efrain, He, Yudong D, Brown, Danielle L, Aguirre, J. Ignacio, Wronski, Thomas J, Buntich, Sabina, Afshari, Cynthia A, Pyrah, Ian, Nioi, Paul, Boyce, Rogely Waite

Volltext

Amitech makes inaugural shipment of Polycrete pipe

Volltext

Sclerostin and DKK1 Inhibition Preserves and Augments Alveolar Bone Volume and Architecture in Rats with Alveolar Bone Loss von Liu, M., Kurimoto, P., Zhang, J., Niu, Q.T., Stolina, M., Dechow, P.C., Feng, J.Q., Hesterman, J., Silva, M.D., Ominsky, M.S., Richards, W.G., Ke, H., Kostenuik, P.J.

Volltext

Targeting WNT signaling in the treatment of osteoporosis von Baron, Roland, Gori, Francesca

Volltext

The Co‐Crystal Approach to Improve the Exposure of a Water‐Insoluble Compound: AMG 517 Sorbic Acid Co‐Crystal Characterization and Pharmacokinetics von Bak, Annette, Gore, Anu, Yanez, Evelyn, Stanton, Mary, Tufekcic, Sunita, Syed, Rashid, Akrami, Anna, Rose, Mark, Surapaneni, Sekhar, Bostick, Tracy, King, Anthony, Neervannan, Sesha, Ostovic, Drazen, Koparkar, Arun

Volltext

Romosozumab in osteoporosis: yesterday, today and tomorrow von Wu, Dong, Li, Lei, Wen, Zhun, Wang, Guangbin

Volltext

Inverse correlation between trabecular bone volume and bone marrow adipose tissue in rats treated with osteoanabolic agents von Costa, Samantha, Fairfield, Heather, Reagan, Michaela R.

Volltext

Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody von Boyce, Rogely Waite, Brown, Danielle, Felx, Melanie, Mellal, Nacera, Locher, Kathrin, Pyrah, Ian, Ominsky, Michael S., Taylor, Scott

Volltext

FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab von Cosman, Felicia, Crittenden, Daria B, Ferrari, Serge, Khan, Aliya, Lane, Nancy E, Lippuner, Kurt, Matsumoto, Toshio, Milmont, Cassandra E, Libanati, Cesar, Grauer, Andreas

Volltext

Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption von Cawley, Keisha M., Bustamante-Gomez, Nancy Cecile, Guha, Anveshi G., MacLeod, Ryan S., Xiong, Jinhu, Gubrij, Igor, Liu, Yu, Mulkey, Robin, Palmieri, Michela, Thostenson, Jeff D., Goellner, Joseph J., O’Brien, Charles A.

Volltext

Sclerostin-Antibody Treatment Decreases Fracture Rates in Axial Skeleton and Improves the Skeletal Phenotype in Growing oim/oim Mice von Cardinal, Mickaël, Dessain, Alicia, Roels, Thomas, Lafont, Sébastien, Ominsky, Michael S., Devogelaer, Jean-Pierre, Chappard, Daniel, Mabilleau, Guillaume, Ammann, Patrick, Nyssen-Behets, Catherine, Manicourt, Daniel H.

Volltext

Sclerostin Inhibition in the Management of Osteoporosis von Appelman-Dijkstra, Natasha M., Papapoulos, Socrates E.

Volltext

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases von Fabre, Stéphanie, Funck-Brentano, Thomas, Cohen-Solal, Martine

Volltext

The Role of Epigenomics in Osteoporosis and Osteoporotic Vertebral Fracture von Kim, Kyoung-Tae, Lee, Young-Seok, Han, Inbo

Volltext